LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL)

Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A

(2012) Jamie L. Dargart et al.   ANTIVIRAL RESEARCH

Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature

(2012) Qing-Xu Yang et al.   Diagnostic Pathology

Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma

(2012) Zi-Ming Du et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor

(2012) Yuan Mao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Down-regulation of BLIMP1  by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas

(2011) K. Vrzalikova et al.   BLOOD

Epstein-Barr virus in Burkitt’s lymphoma: A role for latent membrane protein 2A

(2011) Kathryn T. Bieging et al.   CELL CYCLE

Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand

(2011) Tawatchai Pongpruttipan et al.   Diagnostic Pathology

Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV inf

(2011) Emiko Takahashi et al.   HISTOPATHOLOGY

A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In Vivo

(2011) R. Chen et al.   MOLECULAR CANCER THERAPEUTICS

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

(2010) C. P. Fox et al.   BLOOD

Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment

(2010) Holbrook Kohrt et al.   LEUKEMIA & LYMPHOMA

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

(2009) R. Suzuki et al.   ANNALS OF ONCOLOGY

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion

(2009) Cheng-Hsun Ho et al.   CARCINOGENESIS

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211

(2009) Motoko Yamaguchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study

(2009) Seok Jin Kim et al.   JOURNAL OF CLINICAL ONCOLOGY

Natural killer cell neoplasms

(2008) Xiayuan Liang et al.   CANCER

EBV-Associated Lymphoproliferative Disorders: Classification and Treatment

(2008) A. Carbone et al.   ONCOLOGIST